HKEX:1875 - TOT Biopharm International Co Ltd

Tot Biopharm International Co
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2017 Q4	2018 Q4	2019 Q2	2019 Q4	2020 Q2	2020 Q4	2021 Q2	2021 Q4	2022 Q2	2022 Q4	2023 Q2	2023 Q4	2024 Q2	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	76.32M 134.5%	235.21M 208.2%	442.18M 88.0%	588.22M 33.0%	780.63M 32.7%	973.17M 24.7%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	48.85M 277.3%	63.19M 29.3%	71.56M 13.3%	126.14M 76.3%	206.64M 63.8%	272.28M 31.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	27.47M 40.1%	172.03M 526.1%	370.61M 115.4%	462.08M 24.7%	573.99M 24.2%	700.89M 22.1%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	331.78M 7.9%	385.1M 16.1%	481.01M 24.9%	636.09M 32.2%	819.86M 28.9%	955.75M 16.6%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	282.93M -3.9%	321.91M 13.8%	409.45M 27.2%	509.94M 24.5%	613.22M 20.3%	683.47M 11.5%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-255.45M -	-149.89M -	-38.83M -	-47.86M -	-39.23M -	17.42M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-261.22M -	-	-50.05M -	-	-37.76M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-261.22M -	-161.93M -	-49.92M -	-49.35M -	-37.76M -	8.96M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.46 -	-0.29 -	-0.08 -	-0.07 -	-0.05 -	0.01 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.46 -	-0.29 -	-0.08 -	-0.07 -	-0.05 -	0.01 -